Simplex Trading
SPRY icon

Simplex Trading’s ARS Pharmaceuticals SPRY Stock Holding History

Simplex Trading’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Sell
32,600
-18,700
-36% -$179K ﹤0.01% 3975
2025
Q4 		$598K Buy
51,300
+16,400
+47% +$159K ﹤0.01% 3128
2025
Q3 		$350K Buy
34,900
+18,900
+118% +$271K ﹤0.01% 4271
2025
Q2 		$279K Sell
16,000
-5,000
-24% -$72.1K ﹤0.01% 4162
2025
Q1 		$264K Buy
21,000
+6,900
+49% +$83K ﹤0.01% 4053
2024
Q4 		$148K Sell
14,100
-20,200
-59% -$283K ﹤0.01% 4803
2024
Q3 		$497K Sell
34,300
-93,300
-73% -$1.11M ﹤0.01% 3600
2024
Q2 		$351K Buy
127,600
+52,600
+70% +$467K ﹤0.01% 4048
2024
Q1 		$766K Buy
75,000
+69,600
+1,289% +$519K ﹤0.01% 3405
2023
Q4 		$29K Sell
5,400
-19,100
-78% -$83.7K ﹤0.01% 6602
2023
Q3 		$92K Buy
24,500
+500
+2% +$3.28K ﹤0.01% 5173
2023
Q2 		$160K Sell
24,000
-122,300
-84% -$816K ﹤0.01% 4562
2023
Q1 		$952K Buy
146,300
+20,300
+16% +$156K ﹤0.01% 2638
2022
Q4 		$1.07M Sell
126,000
-144,300
-53% -$936K ﹤0.01% 2393
2022
Q3 		$1.43M Buy
270,300
+11,800
+5% +$58.1K ﹤0.01% 2285
2022
Q2 		$1.1M Buy
258,500
+246,200
+2,002% +$859K ﹤0.01% 2512
2022
Q1 		$43K Buy
+12,300
New +$53.5K ﹤0.01% 7351

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Simplex Trading's SPRY Position: Q2 2025 in Review

Simplex Trading sold out of ARS Pharmaceuticals (SPRY) in Q2 2025, closing a stake of 44,092 shares — an estimated $636K sold.

Simplex Trading first reported a position in SPRY in Q4 2021 and held it in 8 quarters. The position peaked at $806K in Q3 2024. 187 funds tracked by Wall St. Rank hold SPRY as of Q2 2025.

  • Simplex Trading reported no remaining ARS Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 44,092 ARS Pharmaceuticals shares in Q2 2025, an estimated $636K.
  • Simplex Trading first reported a position in ARS Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's ARS Pharmaceuticals position peaked at $806K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.